サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：カルシニューリン阻害剤の世界市場（2022年～2028年）：疾患別、薬剤別、投与経路別、エンドユーザー別、流通チャネル別、地域別の市場規模調査と予測
市場調査レポート
商品コード
1084104

カルシニューリン阻害剤の世界市場（2022年～2028年）：疾患別、薬剤別、投与経路別、エンドユーザー別、流通チャネル別、地域別の市場規模調査と予測

Global Calcineurin Inhibitors Market Size study, By Diseases, Drug, Route of Administration, End-Users, Distribution Channel, and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
カルシニューリン阻害剤の世界市場（2022年～2028年）：疾患別、薬剤別、投与経路別、エンドユーザー別、流通チャネル別、地域別の市場規模調査と予測
出版日: 2022年05月31日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のカルシニューリン阻害剤の市場規模は、2022年～2028年の予測期間中に健全な成長率で拡大すると予想されています。市場を牽引する主な要因には、乾癬有病率の増加、臓器移植症例の増加、また主要企業による最近の製品の発売などがあります。しかし、カルシニューリン阻害剤に伴う副作用が、予測期間における市場の成長を阻害しています。

当レポートでは、世界のカルシニューリン阻害剤市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界のカルシニューリン阻害剤市場：定義と範囲

第3章 世界のカルシニューリン阻害剤：市場力学

  • カルシニューリン阻害剤市場：影響分析（2020年～2028年）

第4章 世界のカルシニューリン阻害剤市場：業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要な投資機会
  • 主要な成功戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19以前およびCOVID-19後の市場シナリオ

第6章 世界のカルシニューリン阻害剤市場：疾患別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • アトピー性皮膚炎
    • 術後免疫抑制
    • 潰瘍性大腸炎
    • 乾癬
    • 角結膜炎
    • その他

第7章 世界のカルシニューリン阻害剤市場：薬剤別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • シクロスポリン
    • タクロリムス
    • ピメクロリムス
    • その他

第8章 世界のカルシニューリン阻害剤市場：投与経路別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • 経口
    • 局所
    • 非経口

第9章 世界のカルシニューリン阻害剤市場：エンドユーザー別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • 病院
    • 専門診療所
    • 在宅医療
    • その他

第10章 世界のカルシニューリン阻害剤市場：流通チャネル別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局
    • その他

第11章 世界のカルシニューリン阻害剤市場：地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第12章 競合情勢

  • 主な市場戦略
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd.（スイス）
    • Mylan N.V.（米国）
    • Teva Pharmaceutical Industries Ltd.（イスラエル）
    • Sanofi（フランス）
    • Pfizer Inc.（米国）
    • GlaxoSmithKline plc（英国）
    • Novartis AG（スイス）
    • AstraZeneca（英国）
    • Johnson & Johnson（米国）
    • Bayer AG（ドイツ）

第13章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Calcineurin Inhibitors Market, report scope
  • TABLE 2. Global Calcineurin Inhibitors Market estimates & forecasts by Region 2018-2028 (USD Million)
  • TABLE 3. Global Calcineurin Inhibitors Market estimates & forecasts by Diseases 2018-2028 (USD Million)
  • TABLE 4. Global Calcineurin Inhibitors Market estimates & forecasts by Drug 2018-2028 (USD Million)
  • TABLE 5. Global Calcineurin Inhibitors Market estimates & forecasts by Route of Administration 2018-2028 (USD Million)
  • TABLE 6. Global Calcineurin Inhibitors Market estimates & forecasts by End-Users 2018-2028 (USD Million)
  • TABLE 7. Global Calcineurin Inhibitors Market estimates & forecasts by Distribution Channel 2018-2028 (USD Million)
  • TABLE 8. Global Calcineurin Inhibitors Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Calcineurin Inhibitors Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Calcineurin Inhibitors Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Calcineurin Inhibitors Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Calcineurin Inhibitors Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Calcineurin Inhibitors Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Calcineurin Inhibitors Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. Global Calcineurin Inhibitors Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. Global Calcineurin Inhibitors Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 17. Global Calcineurin Inhibitors Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 18. U.S. Calcineurin Inhibitors Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 19. U.S. Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 20. U.S. Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 21. Canada Calcineurin Inhibitors Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 22. Canada Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 23. Canada Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 24. UK Calcineurin Inhibitors Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 25. UK Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 26. UK Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 27. Germany Calcineurin Inhibitors Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 28. Germany Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 29. Germany Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 30. RoE Calcineurin Inhibitors Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 31. RoE Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 32. RoE Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 33. China Calcineurin Inhibitors Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 34. China Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 35. China Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 36. India Calcineurin Inhibitors Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 37. India Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 38. India Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 39. Japan Calcineurin Inhibitors Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 40. Japan Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 41. Japan Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 42. RoAPAC Calcineurin Inhibitors Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 43. RoAPAC Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 44. RoAPAC Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 45. Brazil Calcineurin Inhibitors Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 46. Brazil Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 47. Brazil Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 48. Mexico Calcineurin Inhibitors Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 49. Mexico Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 50. Mexico Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 51. RoLA Calcineurin Inhibitors Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 52. RoLA Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 53. RoLA Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 54. Row Calcineurin Inhibitors Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 55. Row Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 56. Row Calcineurin Inhibitors Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 57. List of secondary sources, used in the study of global Calcineurin Inhibitors Market
  • TABLE 58. List of primary sources, used in the study of global Calcineurin Inhibitors Market
  • TABLE 59. Years considered for the study
  • TABLE 60. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Calcineurin Inhibitors Market, research methodology
  • FIG 2. Global Calcineurin Inhibitors Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Calcineurin Inhibitors Market, key trends 2021
  • FIG 5. Global Calcineurin Inhibitors Market, growth prospects 2022-2028
  • FIG 6. Global Calcineurin Inhibitors Market, porters 5 force model
  • FIG 7. Global Calcineurin Inhibitors Market, pest analysis
  • FIG 8. Global Calcineurin Inhibitors Market, value chain analysis
  • FIG 9. Global Calcineurin Inhibitors Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Calcineurin Inhibitors Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Calcineurin Inhibitors Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Calcineurin Inhibitors Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Calcineurin Inhibitors Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Calcineurin Inhibitors Market, regional snapshot 2018 & 2028
  • FIG 15. North America Calcineurin Inhibitors Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Calcineurin Inhibitors Market 2018 & 2028 (USD Million)
  • FIG 17. Asia pacific Market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Calcineurin Inhibitors Market 2018 & 2028 (USD Million)
  • FIG 19. Global Calcineurin Inhibitors Market, company Market share analysis (2021)
目次

Global Calcineurin Inhibitors Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Calcineurin Inhibitors can be defined as immunosuppressants (drugs or medicines that lower the body's ability to reject a transplanted organ) used to manage autoimmune conditions such as lupus nephritis, idiopathic inflammatory myositis, interstitial lung disease, atopic and dermatitis among others. Growing prevalence of prevalence of psoriasis and increasing cases of organ transplant as well as recent product launches from leading market players are key drivers for growth of Calcineurin Inhibitors Market. For instance, according to Global Psoriasis Atlas - as of 2021, around 60 million people are suffering from psoriasis worldwide. Furthermore, in USA around 3.65 million people are affected with psoriasis, whereas in UK around 1.01 million have psoriasis. Moreover, in December 2020, Biopharmaceuticals company Biocon launched Tacrolimus capsules in the US. Tacrolimus, a calcineurin inhibitor, is an immunosuppressant used in the treatment of organ transplant patients. Also, growing number of research and development activities and rising healthcare infrastructure in emerging economies are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, side effects associated with calcineurin inhibitors impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Calcineurin Inhibitors Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to rising R&D activities and increasing prevalence of atopic dermatitis as well as presence of leading market players. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as growing healthcare sector and increasing penetration of global pharmaceuticals companies in the region, would create lucrative growth prospects for the Calcineurin Inhibitors Market across the Asia Pacific region.

Major market players included in this report are:

F. Hoffmann-La Roche Ltd. (Switzerland)

Mylan N.V. (U.S.)

Teva Pharmaceutical Industries Ltd.(Israel)

Sanofi (France)

Pfizer Inc. (U.S.)

GlaxoSmithKline plc (U.K.)

Novartis AG (Switzerland)

AstraZeneca (U.K.)

Johnson & Johnson (U.S.)

Bayer AG (Germany)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Diseases

Atopic Dermatitis

Postoperative Immunosuppression

Ulcerative Colitis

Psoriasis

Keratoconjunctivitis

Others

By Drug

Cyclosporine

Tacrolimus

Pimecrolimus

Others

By Route of Administration

Oral

Topical

Parenteral

By End-Users

Hospitals

Specialty Clinics

Homecare

Others

By Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Calcineurin Inhibitors Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Global Calcineurin Inhibitors Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Global Calcineurin Inhibitors Market, by Diseases, 2020-2028 (USD Million)
    • 1.2.3. Global Calcineurin Inhibitors Market, by Drug, 2020-2028 (USD Million)
    • 1.2.4. Global Calcineurin Inhibitors Market, by Route of Administration, 2020-2028 (USD Million)
    • 1.2.5. Global Calcineurin Inhibitors Market, by End-Users, 2020-2028 (USD Million)
    • 1.2.6. Global Calcineurin Inhibitors Market, by Distribution Channel, 2020-2028 (USD Million)
    • 1.2.7.
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Calcineurin Inhibitors Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Calcineurin Inhibitors Market Dynamics

  • 3.1. Calcineurin Inhibitors Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing prevalence of prevalence of psoriasis.
      • 3.1.1.2. Increasing cases of organ transplant.
      • 3.1.1.3. Recent product launches from leading Market players.
    • 3.1.2. Market Challenges
      • 3.1.2.1. Side effects associated with calcineurin inhibitors.
      • 3.1.2.2.
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing number of research and development activities
      • 3.1.3.2. Rising healthcare infrastructure in emerging economies.

Chapter 4. Global Calcineurin Inhibitors Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Calcineurin Inhibitors Market, by Diseases

  • 6.1. Market Snapshot
  • 6.2. Global Calcineurin Inhibitors Market by Diseases, Performance - Potential Analysis
  • 6.3. Global Calcineurin Inhibitors Market Estimates & Forecasts by Diseases 2018-2028 (USD Million)
  • 6.4. Calcineurin Inhibitors Market, Sub Segment Analysis
    • 6.4.1. Atopic Dermatitis
    • 6.4.2. Postoperative Immunosuppression
    • 6.4.3. Ulcerative Colitis
    • 6.4.4. Psoriasis
    • 6.4.5. Keratoconjunctivitis
    • 6.4.6. Others

Chapter 7. Global Calcineurin Inhibitors Market, by Drug

  • 7.1. Market Snapshot
  • 7.2. Global Calcineurin Inhibitors Market by Drug, Performance - Potential Analysis
  • 7.3. Global Calcineurin Inhibitors Market Estimates & Forecasts by Drug 2018-2028 (USD Million)
  • 7.4. Calcineurin Inhibitors Market, Sub Segment Analysis
    • 7.4.1. Cyclosporine
    • 7.4.2. Tacrolimus
    • 7.4.3. Pimecrolimus
    • 7.4.4. Others

Chapter 8. Global Calcineurin Inhibitors Market, by Route of Administration

  • 8.1. Market Snapshot
  • 8.2. Global Calcineurin Inhibitors Market by Route of Administration, Performance - Potential Analysis
  • 8.3. Global Calcineurin Inhibitors Market Estimates & Forecasts by Route of Administration 2018-2028 (USD Million)
  • 8.4. Calcineurin Inhibitors Market, Sub Segment Analysis
    • 8.4.1. Oral
    • 8.4.2. Topical
    • 8.4.3. Parenteral

Chapter 9. Global Calcineurin Inhibitors Market, by End-Users

  • 9.1. Market Snapshot
  • 9.2. Global Calcineurin Inhibitors Market by End-Users, Performance - Potential Analysis
  • 9.3. Global Calcineurin Inhibitors Market Estimates & Forecasts by End-Users 2018-2028 (USD Million)
  • 9.4. Calcineurin Inhibitors Market, Sub Segment Analysis
    • 9.4.1. Hospitals
    • 9.4.2. Specialty Clinics
    • 9.4.3. Homecare
    • 9.4.4. Others

Chapter 10. Global Calcineurin Inhibitors Market, by Distribution Channel

  • 10.1. Market Snapshot
  • 10.2. Global Calcineurin Inhibitors Market by Distribution Channel, Performance - Potential Analysis
  • 10.3. Global Calcineurin Inhibitors Market Estimates & Forecasts by Distribution Channel 2018-2028 (USD Million)
  • 10.4. Calcineurin Inhibitors Market, Sub Segment Analysis
    • 10.4.1. Hospital Pharmacy
    • 10.4.2. Retail Pharmacy
    • 10.4.3. Online Pharmacy
    • 10.4.4. Others

Chapter 11. Global Calcineurin Inhibitors Market, Regional Analysis

  • 11.1. Calcineurin Inhibitors Market, Regional Market Snapshot
  • 11.2. North America Calcineurin Inhibitors Market
    • 11.2.1. U.S. Calcineurin Inhibitors Market
      • 11.2.1.1. Diseases estimates & forecasts, 2018-2028
      • 11.2.1.2. Drug estimates & forecasts, 2018-2028
      • 11.2.1.3. Route of Administration estimates & forecasts, 2018-2028
      • 11.2.1.4. End-Users estimates & forecasts, 2018-2028
      • 11.2.1.5. Distribution Channel estimates & forecasts, 2018-2028
    • 11.2.2. Canada Calcineurin Inhibitors Market
  • 11.3. Europe Calcineurin Inhibitors Market Snapshot
    • 11.3.1. U.K. Calcineurin Inhibitors Market
    • 11.3.2. Germany Calcineurin Inhibitors Market
    • 11.3.3. France Calcineurin Inhibitors Market
    • 11.3.4. Spain Calcineurin Inhibitors Market
    • 11.3.5. Italy Calcineurin Inhibitors Market
    • 11.3.6. Rest of Europe Calcineurin Inhibitors Market
  • 11.4. Asia-Pacific Calcineurin Inhibitors Market Snapshot
    • 11.4.1. China Calcineurin Inhibitors Market
    • 11.4.2. India Calcineurin Inhibitors Market
    • 11.4.3. Japan Calcineurin Inhibitors Market
    • 11.4.4. Australia Calcineurin Inhibitors Market
    • 11.4.5. South Korea Calcineurin Inhibitors Market
    • 11.4.6. Rest of Asia Pacific Calcineurin Inhibitors Market
  • 11.5. Latin America Calcineurin Inhibitors Market Snapshot
    • 11.5.1. Brazil Calcineurin Inhibitors Market
    • 11.5.2. Mexico Calcineurin Inhibitors Market
  • 11.6. Rest of The World Calcineurin Inhibitors Market

Chapter 12. Competitive Intelligence

  • 12.1. Top Market Strategies
  • 12.2. Company Profiles
    • 12.2.1. F. Hoffmann-La Roche Ltd. (Switzerland)
      • 12.2.1.1. Key Information
      • 12.2.1.2. Overview
      • 12.2.1.3. Financial (Subject to Data Availability)
      • 12.2.1.4. Product Summary
      • 12.2.1.5. Recent Developments
    • 12.2.2. Mylan N.V. (U.S.)
    • 12.2.3. Teva Pharmaceutical Industries Ltd. (Israel)
    • 12.2.4. Sanofi (France)
    • 12.2.5. Pfizer Inc. (U.S.)
    • 12.2.6. GlaxoSmithKline plc (U.K.)
    • 12.2.7. Novartis AG (Switzerland)
    • 12.2.8. AstraZeneca (U.K.)
    • 12.2.9. Johnson & Johnson (U.S.)
    • 12.2.10. Bayer AG (Germany)

Chapter 13. Research Process

  • 13.1. Research Process
    • 13.1.1. Data Mining
    • 13.1.2. Analysis
    • 13.1.3. Market Estimation
    • 13.1.4. Validation
    • 13.1.5. Publishing
  • 13.2. Research Attributes
  • 13.3. Research Assumption